Heart Attacks Surge After Weed?

Three cannabis joints beside loose marijuana buds
Photo: Craig F Scott / Shutterstock

A sixfold jump in heart-attack risk showed up in young cannabis users, and it came from a massive medical-records study, not a scare graphic.

At a Glance

  • A 4.6 million–person analysis linked cannabis use under age 50 to far higher rates of major heart events.
  • Reported risks spanned heart attack, stroke, heart failure, and a combined cardiovascular endpoint.
  • Absolute risk stayed low, but relative differences were large and consistent across outcomes.
  • Some studies in older, sicker groups found no added risk from recent cannabis smoking.

What the big study actually found, in plain numbers

Researchers analyzed electronic medical records for 4,636,628 people under 50 who lacked conditions like high blood pressure, diabetes, or tobacco use, and flagged 93,267 as cannabis users. Reported heart-attack events were 0.558% in users and 0.09% in nonusers, a risk ratio of 6.185. Stroke risk was about four times higher, and risks rose for heart failure and a combined outcome of cardiovascular death, heart attack, or stroke. The absolute heart-attack difference was under half a percentage point, yet the gap was real and wide.

The study appeared in a peer-reviewed cardiology journal and ran with the American College of Cardiology meeting cycle, which boosts its visibility. A separate pooled look at past work cited by the college found about a 50% higher heart-attack risk among cannabis users, smaller than the new study’s signal but pointing in the same direction. The take-home for younger adults is simple: the usual “I’m too young for heart issues” shield looks thinner when cannabis enters the picture.

Where the edges blur: design limits and exposure gaps

The core study was observational and retrospective. That matters. Observational designs show association, not proof of cause. Exposure can be mismeasured, confounders can linger, and users can differ from nonusers in hidden ways. The public summaries do not confirm whether the cannabis was smoked or eaten, how strong the products were, or how often people used them. These gaps do not erase the signal, but they do cap how far any claim should go about occasional use in particular.

The absolute risks also deserve a level head. A sixfold jump on a small base still yields a small number of total events. That is good news for any one person, yet it can be bad news at scale. Millions use cannabis. Small percentages can add up to crowded emergency rooms. Public health decisions should weigh both the size of the relative gaps and the real-world counts they could produce if use keeps rising.

Contrasting results in older adults with heart disease

A separate study in the journal Circulation followed older veterans who already had coronary artery disease. It found that self-reported cannabis smoking in the past 30 days was not independently linked to a combined outcome of heart attack, stroke, or cardiovascular death. The adjusted hazard ratio was 0.87, with a confidence range that crossed 1.0, meaning no clear added risk in that group. This result highlights how age, baseline illness, and exposure tracking can flip the headline.

Why the split? Younger, healthier people may respond differently to cannabis or to smoke exposure than older patients on heart medications. Self-report versus medical-record coding can point in different directions. Dose, route, and product strength vary widely. Common sense says not to cherry-pick the study you like. The prudent path is to note the strong risk signal in younger users and the uncertainty in other groups, while asking for better exposure data and dose-response testing.

Practical takeaways that respect both freedom and risk

Adults deserve clear facts. The best evidence today says cannabis use under 50 links to higher odds of major heart events, across several outcomes, in a very large dataset. That does not prove that a few weekend puffs will cause a heart attack. It does say the heart is part of the cost column, not just the lungs or the brain. Personal responsibility means weighing risks with eyes open, the same way many people already do with alcohol and tobacco.

Policy should follow data, not vibes. Health warnings should focus on method of use, dose, and age. Labels should avoid hype but not hide risk. Researchers should run prospective studies that verify use with tests, sort smoking from edibles, and track potency over time. Until then, the fairest rule of thumb is simple: fewer inhaled toxins, fewer surprises. If you choose to use, know your product, keep doses lower, skip smoke when you can, and watch any chest, jaw, or arm pain like your life depends on it—because one day, it might.

Sources:

facebook.com, acc.org, jacc.org, pubmed.ncbi.nlm.nih.gov

© 2026 Reliable News. All Rights Reserved.